[
  {
    "ts": "2026-01-29T12:00:00+00:00",
    "headline": "Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs",
    "summary": "TORONTO, January 29, 2026--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (\"Satellos\" or the \"Company\"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer (\"CDO\") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at",
    "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c68f7375-0e80-358f-998e-c17fe8dfe2bb",
      "content": {
        "id": "c68f7375-0e80-358f-998e-c17fe8dfe2bb",
        "contentType": "STORY",
        "title": "Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs",
        "description": "",
        "summary": "TORONTO, January 29, 2026--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (\"Satellos\" or the \"Company\"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced the appointment of Antoinette Paone as Chief Development Officer (\"CDO\") and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at",
        "pubDate": "2026-01-29T12:00:00Z",
        "displayTime": "2026-01-29T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec",
          "originalWidth": 1301,
          "originalHeight": 302,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7KvzPNqU74cGoR_dPhKVBw--~B/aD0zMDI7dz0xMzAxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec.cf.webp",
              "width": 1301,
              "height": 302,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mLfluk1k4K2RaiFTiwM5ZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8517e436bf81071d9109b04c99a35bec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/satellos-appoints-antoinette-paone-chief-120000268.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GBIO"
            },
            {
              "symbol": "MSCLF"
            },
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T14:20:00+00:00",
    "headline": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals",
    "summary": "The biotech could be on the verge of expanding its lineup and entering a new era of growth.",
    "url": "https://www.fool.com/investing/2026/01/29/prediction-2026-will-be-the-year-of-healthcare-sto/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "773e55c2-c9aa-3b53-b74d-81c1709101bb",
      "content": {
        "id": "773e55c2-c9aa-3b53-b74d-81c1709101bb",
        "contentType": "STORY",
        "title": "Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals",
        "description": "",
        "summary": "The biotech could be on the verge of expanding its lineup and entering a new era of growth.",
        "pubDate": "2026-01-29T14:20:00Z",
        "displayTime": "2026-01-29T14:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd",
          "originalWidth": 1400,
          "originalHeight": 738,
          "caption": "Person raising both fists in the air.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u9h0gTWHULOW94a.fEqIdQ--~B/aD03Mzg7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd.cf.webp",
              "width": 1400,
              "height": 738,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/K5dsZwa.n296tJnKOnRbjg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/2ce8d02368c14928d98f1679c1a7e9cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/29/prediction-2026-will-be-the-year-of-healthcare-sto/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/prediction-2026-vertex-pharmaceuticals-142000459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-29T04:34:25+00:00",
    "headline": "1 Healthcare Stock to Consider Right Now and 2 We Brush Off",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 17.1% over the past six months while the S&P 500 was up 9.5%.",
    "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043425487.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "8c34f59e-a36d-3892-b478-f1327c4455a6",
      "content": {
        "id": "8c34f59e-a36d-3892-b478-f1327c4455a6",
        "contentType": "STORY",
        "title": "1 Healthcare Stock to Consider Right Now and 2 We Brush Off",
        "description": "",
        "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 17.1% over the past six months while the S&P 500 was up 9.5%.",
        "pubDate": "2026-01-29T04:34:25Z",
        "displayTime": "2026-01-29T04:34:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/deb3d79d2e2c41377b0b2ebb8ef2e4cd",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "VRTX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l6Y31wu10RiElUns.3mORA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/deb3d79d2e2c41377b0b2ebb8ef2e4cd.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qe_uhCRKlCGgByoENi3GZg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/deb3d79d2e2c41377b0b2ebb8ef2e4cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043425487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043425487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "OMCL"
            },
            {
              "symbol": "SUPN"
            },
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]